Short answer
Albemarle Corporation (ALB) filed its Q3 2025 10-Q quarterly report on Nov 5, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $1.3B (down 3.5% year over year) with net income of −$161M.
Q3 2025 key financials · XBRL
- Revenue
- $1.3B
- −3.5% YoY · −1.7% QoQ
- Net income
- −$161M
- +85.0% YoY · −801.8% QoQ
- Operating margin
- -16.6%
- Gross margin
- 9.0%
- EPS (diluted)
- −$1.72
- +81.8% YoY · −975.0% QoQ
Source: XBRL data from the Albemarle Corporation (ALB) Q3 2025 10-Q on SEC EDGAR. USD.
Albemarle Corporation Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $1.31B Q3 2025, down 3% YoY from $1.35B Q3 2024, driven by $131.7M lower lithium pricing offset by $75.7M higher volume
- Operating (gross) margin 9.0% Q3 2025 vs loss margin (7.7%) Q3 2024, due to lower input costs and higher volume
- Best segment: Specialties EBITDA $75.5M up 34% YoY (+$19.3M); Worst segment: Energy Storage EBITDA $124.1M down 13% YoY (-$18.8M)
- Operating cash flow $355.6M Q3 2025, up 57% YoY; cash and equivalents increased to $1.9B (+$739.5M since Dec 2024) due to customer prepayment and preferred equity redemption
- Near-term outlook: Expect Energy Storage sales and profitability declines due to lower lithium prices; capital expenditures cut to ~$600M in 2025; announced divestitures to complete in H1 2026 providing ~$660M liquidity for debt reduction
Risk Factors
- New risk: Goodwill impairment $181.1M on Refining Solutions triggered by planned divestiture agreements signed Oct 2025, indicating fair value below carrying value
- Updated operational risk: Restructuring related to Kemerton plants and Chengdu conversion led to $5.8M charges in YTD 2025 versus $1.2B in full 2024; reflects ongoing cost optimization
- Regulatory/legal risk: Conclusion of U.S. DOJ non-prosecution agreement in Apr 2025 following 2018 self-reported matter, reducing legal uncertainty but potential legacy liabilities remain
- Market risk: Declining lithium prices caused inventory writedowns $11.1M in Q3 2025, down from $104.0M in 2024, pressuring gross margins and near-term earnings
- Financial risk: Cash $1.93B at Sep 30, 2025 up from $1.19B year-end 2024; long-term debt $3.63B with near-term maturities $445M; sales under receivables purchase agreement $106.6M YTD 2025
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Albemarle Corporation quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.